91 related articles for article (PubMed ID: 516578)
21. Quantitation of cell-mediated immunity: responses to dinitrochlorobenzene and ubiquitous antigens.
Thompson CD; Whittingham S; Mackay IR; Khoo SK; Toh BH; Stagg RJ
Can Med Assoc J; 1975 May; 112(9):1078-81. PubMed ID: 1079163
[TBL] [Abstract][Full Text] [Related]
22. Cross-reactions between DNCB and DNFB.
Ortega Resinas M; García Pérez A
Allergol Immunopathol (Madr); 1983; 11(1):47-9. PubMed ID: 6858807
[No Abstract] [Full Text] [Related]
23. [Characteristics of antitumor immunity in different forms of chronic gastritis].
Ostrovskiĭ AB
Vopr Onkol; 1984; 30(7):70-4. PubMed ID: 6331684
[TBL] [Abstract][Full Text] [Related]
24. A technique for intensifying BCG sensitivity.
Parmett SR; Klein E
J Med; 1975; 6(3-4):213-6. PubMed ID: 1104733
[TBL] [Abstract][Full Text] [Related]
25. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
26. [DNCB-skin specimens for immunodiagnosis].
Sinn W
Z Gesamte Inn Med; 1981 Sep; 36(17):602-7. PubMed ID: 7345806
[TBL] [Abstract][Full Text] [Related]
27. [Study of humoral and cellular immunity in normal subjects and in patients with gastric cancer, gastric ulcer an chronic gastritis].
Dávila M; Silva M; Rufin F; Ruíz F; Ugarte JM; Díaz H
Rev Med Chil; 1974 May; 102(5):353-8. PubMed ID: 4471398
[No Abstract] [Full Text] [Related]
28. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
Osoba D; Kersey PA; Clark RM; Rosen IB
Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
[TBL] [Abstract][Full Text] [Related]
29. Impaired cell-mediated immunity in patients with kala-azar.
Hepner Levy L; Mendes E
Allergol Immunopathol (Madr); 1981; 9(2):109-12. PubMed ID: 7293874
[TBL] [Abstract][Full Text] [Related]
30. [Algorithm of immunomorphological criteria of diagnosis of gastric mucosa dysplasias and early cancer in stomach biopsies].
Khmel'nitskiĭ OK; Sarantsev BV
Arkh Patol; 2000; 62(5):43-5. PubMed ID: 11076299
[TBL] [Abstract][Full Text] [Related]
31. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
32. [Skin tests of delayed hypersensitivity (tuberculin, DNCB) in the immunologic study of patients with primary cancer of the lung].
Bariffi F; Illiano A; Tranfa CM; Del Prato B
Arch Monaldi; 1978; 33(4):239-50. PubMed ID: 756707
[No Abstract] [Full Text] [Related]
33. [Immunological status of patients with stomach cancer].
Kliachkin BM
Sov Med; 1976 Aug; (8):97-100. PubMed ID: 795047
[No Abstract] [Full Text] [Related]
34. [DNCB test and immune competence. Analysis of patients with urologic neoplasms].
Klippel KF; Walz HP; Kreutz G; von Moltke T
MMW Munch Med Wochenschr; 1978 Aug; 120(31):1027-8. PubMed ID: 308155
[No Abstract] [Full Text] [Related]
35. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
Plesnicar S; Rudolf Z; Lavrencic D
Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
[TBL] [Abstract][Full Text] [Related]
36. Cell-mediated immunity in Hurler's syndrome.
Mendes E; Toledo SP
Allergol Immunopathol (Madr); 1975; 3(2):95-8. PubMed ID: 808113
[TBL] [Abstract][Full Text] [Related]
37. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.
Rao B; Wanebo HJ; Pinsky C; Stearns M; Oettgen HF
Surg Gynecol Obstet; 1977 May; 144(5):677-81. PubMed ID: 850850
[TBL] [Abstract][Full Text] [Related]
38. Immunological responsiveness in patients with bladder cancer.
Fahey JL; Brosman S; Dorey F
Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
[TBL] [Abstract][Full Text] [Related]
39. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
Ruszel KB
Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
[No Abstract] [Full Text] [Related]
40. Immunologic defects in lung cancer patients.
Holmes EC; Golub SH
J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
